SPRO – Spero Therapeutics, Inc.
Spero Therapeutics, Inc.SPRO
$1.01Name : Spero Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $58,817,176.00
EPSttm : 0.14
Spero Therapeutics, Inc.
$1.01
5.61%$0.06
SPRO — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
1.96
Margin Of Safety %
57
Put/Call OI Ratio
0.41
EPS Next Q Diff
EPS Last/This Y
-0.73
EPS This/Next Y
0.47
Price
1.01
Target Price
6
Analyst Recom
1
Performance Q
-15.13
Upside
41.6%
Beta
1.56
Ticker: SPRO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | SPRO | 1.19 | 0.26 | 0.60 | 8664 |
| 2026-10-13 | SPRO | 1.15 | 0.26 | 1.57 | 8693 |
| 2026-10-14 | SPRO | 1.11 | 0.26 | 3.40 | 8688 |
| 2026-10-15 | SPRO | 1.135 | 0.26 | 5.00 | 8670 |
| 2026-10-16 | SPRO | 1.105 | 0.26 | 999.99 | 8666 |
| 2026-10-19 | SPRO | 1.125 | 0.45 | 0.00 | 3827 |
| 2026-10-20 | SPRO | 1.22 | 0.45 | 3.20 | 3837 |
| 2026-10-21 | SPRO | 1.175 | 0.45 | 999.99 | 3853 |
| 2026-10-22 | SPRO | 1.135 | 0.45 | 999.99 | 3854 |
| 2026-10-23 | SPRO | 1.11 | 0.45 | 0.90 | 3854 |
| 2026-10-26 | SPRO | 1.065 | 0.45 | 2.33 | 3832 |
| 2026-10-27 | SPRO | 1.12 | 0.44 | 0.09 | 3813 |
| 2026-10-28 | SPRO | 1.17 | 0.42 | 0.90 | 3916 |
| 2026-10-29 | SPRO | 1.115 | 0.42 | 0.18 | 3909 |
| 2026-10-30 | SPRO | 1.06 | 0.41 | 0.60 | 3958 |
| 2026-11-02 | SPRO | 1.04 | 0.41 | 22.00 | 3963 |
| 2026-11-03 | SPRO | 1.0462 | 0.41 | 24.00 | 3967 |
| 2026-11-04 | SPRO | 1.06 | 0.41 | 7.00 | 3970 |
| 2026-11-05 | SPRO | 1.01 | 0.42 | 1.18 | 3972 |
| 2026-11-06 | SPRO | 1.035 | 0.41 | 5.33 | 3994 |
| 2026-11-09 | SPRO | 1.07 | 0.41 | 1.65 | 3994 |
| 2026-11-10 | SPRO | 1.03 | 0.41 | 19.00 | 3994 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | SPRO | 1.18 | - | - | -0.58 |
| 2026-10-13 | SPRO | 1.16 | - | - | -0.58 |
| 2026-10-14 | SPRO | 1.11 | - | - | -0.58 |
| 2026-10-15 | SPRO | 1.13 | - | - | -0.58 |
| 2026-10-16 | SPRO | 1.10 | - | - | -0.58 |
| 2026-10-19 | SPRO | 1.12 | - | - | -0.58 |
| 2026-10-20 | SPRO | 1.12 | - | - | -0.58 |
| 2026-10-21 | SPRO | 1.22 | - | - | -0.58 |
| 2026-10-22 | SPRO | 1.13 | - | - | -0.58 |
| 2026-10-23 | SPRO | 1.11 | - | - | -0.58 |
| 2026-10-26 | SPRO | 1.07 | - | - | -0.58 |
| 2026-10-27 | SPRO | 1.13 | - | - | -0.58 |
| 2026-10-28 | SPRO | 1.17 | - | - | -0.58 |
| 2026-10-29 | SPRO | 1.12 | - | - | -0.58 |
| 2026-10-30 | SPRO | 1.07 | - | - | -0.58 |
| 2026-11-02 | SPRO | 1.05 | - | - | -0.58 |
| 2026-11-03 | SPRO | 1.04 | - | - | -0.58 |
| 2026-11-04 | SPRO | 1.06 | - | - | -0.58 |
| 2026-11-05 | SPRO | 1.01 | - | - | -0.58 |
| 2026-11-06 | SPRO | 1.03 | - | - | -0.58 |
| 2026-11-09 | SPRO | 1.08 | - | - | -0.58 |
| 2026-11-10 | SPRO | 1.01 | - | - | -0.58 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | SPRO | -0.17 | 1.76 | 1.85 |
| 2026-10-13 | SPRO | -0.17 | 1.76 | 1.85 |
| 2026-10-14 | SPRO | -0.17 | 1.76 | 1.85 |
| 2026-10-15 | SPRO | -0.17 | 1.76 | 1.85 |
| 2026-10-16 | SPRO | -0.17 | 1.76 | 1.85 |
| 2026-10-19 | SPRO | -0.17 | 1.63 | 1.85 |
| 2026-10-20 | SPRO | -0.17 | 1.63 | 1.85 |
| 2026-10-21 | SPRO | -0.17 | 1.63 | 1.85 |
| 2026-10-22 | SPRO | -0.17 | 1.63 | 1.85 |
| 2026-10-23 | SPRO | -0.17 | 1.63 | 1.85 |
| 2026-10-26 | SPRO | -0.17 | 1.65 | 1.85 |
| 2026-10-27 | SPRO | -0.17 | 1.65 | 1.96 |
| 2026-10-28 | SPRO | -0.17 | 1.65 | 1.96 |
| 2026-10-29 | SPRO | -0.17 | 1.65 | 1.96 |
| 2026-10-30 | SPRO | -0.17 | 1.65 | 1.96 |
| 2026-11-02 | SPRO | -0.17 | 1.47 | 1.96 |
| 2026-11-03 | SPRO | -0.17 | 1.47 | 1.96 |
| 2026-11-05 | SPRO | -0.17 | 1.47 | 1.96 |
| 2026-11-06 | SPRO | -0.17 | 1.47 | 1.96 |
| 2026-11-09 | SPRO | 0.00 | 4.80 | 1.96 |
| 2026-11-10 | SPRO | 0.00 | 4.80 | 1.96 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.14
Avg. EPS Est. Next Quarter
-0.14
Insider Transactions
Institutional Transactions
4.8
Beta
1.56
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
1.6
Quality Score
65
Growth Score
40
Sentiment Score
55
Actual DrawDown %
94.2
Max Drawdown 5-Year %
-96.8
Target Price
6
P/E
9.25
Forward P/E
PEG
P/S
1.37
P/B
1.33
P/Free Cash Flow
3
EPS
0.11
Average EPS Est. Cur. Y
-0.58
EPS Next Y. (Est.)
-0.1
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
17.18
Relative Volume
0.33
Return on Equity vs Sector %
-9.6
Return on Equity vs Industry %
10.1
EPS 1 7Days Diff
-0.3
EPS 1 30Days Diff
-0.29
EBIT Estimation
◆
SPRO
Healthcare
$1.01
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
40
Range 1M
24.7%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-746.7%
EPS NY
4.1%
52W%
3.3%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+232.7% upside
Upside
+232.7%
Quality
65
MoS
57%
SPRO — P/E HistoricalBiotechnology
Spero Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 25
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adult patients, which has completed second Phase 3 trial. It has license agreement with Meiji Seika Pharma Co., Ltd. to develop, manufacture, and commercialize tebipenem pivoxil and tebipenem HBr; and Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries. Spero Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
SPRO
Latest News
—
Caricamento notizie per SPRO…
stock quote shares SPRO – Spero Therapeutics, Inc. Stock Price stock today
news today SPRO – Spero Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch SPRO – Spero Therapeutics, Inc. yahoo finance google finance
stock history SPRO – Spero Therapeutics, Inc. invest stock market
stock prices SPRO premarket after hours
ticker SPRO fair value insiders trading